PB
Pausali Banerji Panda
About Pausali Banerji Panda
Data last updated:
Pausali Banerji Panda is a Director at Ordell Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Ordell Pharmaceuticals Private Limited reported revenue of ₹10,000 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ordell Pharmaceuticals Private Limited U46497WB2023PTC264355 | Director | 20 Aug 2023 | 2023 | ₹10,000 (FY 2024) | Active |
Board colleagues of Pausali Banerji Panda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajen Panda | 10285378 | Ordell Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pausali Banerji Panda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pausali Banerji Panda
Pausali Banerji Panda currently holds 1 directorship: Ordell Pharmaceuticals Private Limited (Director, since 20 Aug 2023, revenue ₹10,000 (FY 2024)).
Pausali Banerji Panda was first appointed on 20 Aug 2023 as Director at Ordell Pharmaceuticals Private Limited.
The current boards of Pausali Banerji Panda's companies include Rajen Panda (Ordell Pharmaceuticals Private Limited).